Evidence map›Paper›PMID 41688513›Full record

ArticleScientific reports2026

Comparative spectral analysis of blood and saliva in breast cancer, benign breast disease and healthy controls using ATR-FTIR.

Lara de Andrade Marques, Alinne Tatiane Faria Silva, Izabella Cristina Costa Ferreira, Letícia Lopes Dantas Santos, Juliana Carvalho Penha Pereira, Donizeti William Santos, Carlos Eduardo Paiva, Yara Cristina de Paiva Maia

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lara de Andrade MarquesMolecular Biology and Nutrition Research Group, School of Medicine, Graduate Program in Health Science, Federal University of Uberlandia (UFU), Av. Amazonas sn, Block 2E, 2° Floor, Room 210, Campus Umuarama, Uberlandia, 38405-320, MG, Brazil.
Alinne Tatiane Faria SilvaTeaching and Research Institute, Barretos Cancer Hospital, R. Antenor Duarte Vilela, 1331, Doutor Paulo Prata, Barretos, 14784-400, SP, Brazil.
Izabella Cristina Costa FerreiraMolecular Biology and Nutrition Research Group, School of Medicine, Graduate Program in Health Science, Federal University of Uberlandia (UFU), Av. Amazonas sn, Block 2E, 2° Floor, Room 210, Campus Umuarama, Uberlandia, 38405-320, MG, Brazil.
Letícia Lopes Dantas SantosMolecular Biology and Nutrition Research Group, School of Medicine, Graduate Program in Health Science, Federal University of Uberlandia (UFU), Av. Amazonas sn, Block 2E, 2° Floor, Room 210, Campus Umuarama, Uberlandia, 38405-320, MG, Brazil.
Juliana Carvalho Penha PereiraMolecular Biology and Nutrition Research Group, School of Medicine, Graduate Program in Health Science, Federal University of Uberlandia (UFU), Av. Amazonas sn, Block 2E, 2° Floor, Room 210, Campus Umuarama, Uberlandia, 38405-320, MG, Brazil.
Donizeti William SantosOncology Division, Gynecology Department, University Hospital, Federal University of Uberlandia (UFU), Av. Pará, 1720, Block 2H, Campus Umuarama, Uberlandia, 38405-320, MG, Brazil.
Carlos Eduardo PaivaTeaching and Research Institute, Barretos Cancer Hospital, R. Antenor Duarte Vilela, 1331, Doutor Paulo Prata, Barretos, 14784-400, SP, Brazil.
Yara Cristina de Paiva MaiaMolecular Biology and Nutrition Research Group, School of Medicine, Graduate Program in Health Science, Federal University of Uberlandia (UFU), Av. Amazonas sn, Block 2E, 2° Floor, Room 210, Campus Umuarama, Uberlandia, 38405-320, MG, Brazil. yara.maia@ufu.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 409482/2021-8Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-01961-23Fundação de Amparo à Pesquisa do Estado de Minas Gerais [REMITRIBIC] RED-00031-21
6 · The paper itself

Abstract

Breast cancer (BC) ranks among the most prevalent tumors affecting women. This research explores the ability of Attenuated Total Reflection Infrared Spectroscopy (ATR-FTIR) to identify different biochemical elements found in bodily fluids such as serum and saliva from individuals with BC, individuals with benign breast disease (BBD), and healthy individuals. A cross-sectional analysis was performed on samples from 73 participants, comprising 31 with BC, 18 with BBD, and 24 healthy subjects, to examine biochemical differences across the groups. The findings indicated that the levels of the biochemical elements nucleic acids, proteins, lipids and glycogen significantly differed among the fluids. Specifically, the wavenumber of 2930 cm− 1 in saliva was capable of statistically differentiating BC patients from BBD patients and healthy controls. In the serum samples, a significant difference was observed at 1295 cm− 1 (p = 0.0014). However, serum collection has some disadvantages such as invasiveness and the need for trained personnel. Wavenumbers in saliva have emerged as potential breast cancer biomarkers, suggesting that this approach could serve as a valuable, noninvasive method and readily available option for breast cancer screening. ATR-FTIR spectroscopy has the potential to pave the way for the investigation of more efficient and less invasive clinical diagnostic methods.

Indexed as

Breast DiseasesBreast NeoplasmsSalivaAdultAgedBiomarkers, TumorCase-Control StudiesCross-Sectional StudiesFemaleHumansMiddle AgedSpectroscopy, Fourier Transform InfraredBiomarkers, TumorBiomarkersDNA fingerprintingLipidsNucleic acidsSalivaSerum

Identifiers

PMID41688513
PMCPMC12996439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.